Qinghua Zhang

ORCID: 0000-0002-6184-0308 · 6 papers in corpus
observational 2026
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2026.115364

OBJECTIVES: To evaluate the long-term therapeutic efficacy of laparoscopy combined with transvaginal ultrasound-guided microwave ablation (MWA) for adenomyosis and to identify independent risk factors for postoperative symptomatic recurrenc…

nonrandomized-trial 2023
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group ·doi:10.1080/02656736.2023.2233713

OBJECTIVES: Transvaginal ultrasound- and laparoscopy-guided percutaneous microwave ablation (TLPMA) is a minimally invasive alternative technique with low risk, fast recovery and few side effects. We aimed to evaluate the safety and long-te…

nonrandomized-trial 2023
·doi:10.6084/m9.figshare.23699809

Transvaginal ultrasound- and laparoscopy-guided percutaneous microwave ablation (TLPMA) is a minimally invasive alternative technique with low risk, fast recovery and few side effects. We aimed to evaluate the safety and long-term efficacy …

review 2021
Frontiers in oncology ·doi:10.3389/fonc.2021.603932

The RNA-binding motif protein 10 (RBM10) is involved in alternative splicing and modifies mRNA post-transcriptionally. RBM10 is abnormally expressed in the lung, breast, and colorectal cancer, female genital tumors, osteosarcoma, and other …

other 2019
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group ·doi:10.1080/02656736.2019.1690169

Purpose: Adenomyosis is a relatively common disease among women of childbearing age. A minimally invasive alternative technique with low risks, faster recovery and decreased side effects is desired. We hypothesized that percutaneous microwa…

observational 2016
Oncotarget ·doi:10.18632/oncotarget.8245

BACKGROUND: Most cervical cancer patients worldwide receive surgical treatments, and yet the current International Federation of Gynecology and Obstetrics (FIGO) staging system do not consider surgical-pathologic data. We propose a more com…